Cephalosporins in Urinary Tract Infection
Despite their greater cost compared with other antibiotics, the cephalosporins continue to be used in the treatment of urinary tract infections. Most cephalosporins are excreted primarily by the kidney (by glomerular filtration, tubular secretion, or both) and urinary concentrations routinely exceed 1000 mg/L after even a small dose; exceptions include cefoperazone and ceftriaxone which both exhibit significant biliary excretion, and in patients with significant renal dysfunction only minimal concentrations of these drugs may be present in the urine.
Although single-dose treatment of uncomplicated lower urinary tract infections with oral cephalosporins has not been as effective as with other antibiotics, cephalexin, cephradine and cefaclor continue to be used. Early clinical trials with cefuroxime axetil also appear promising for short term and single-dose therapy. The parenteral cephalosporins are reserved for use against more resistant strains or in hospitalised patients with upper urinary tract infections, their choice being directed by in vitro susceptibility tests. Newer agents such as ceftazidime and cefsulodin have been shown to be effective in infections due to P. aeruginosa.
Recommended cephalosporin dosage regimens for the common urinary tract pathogens are given.
KeywordsUrinary Tract Infection Cephalosporin Bacteriuria Cephalexin Cefaclor
Unable to display preview. Download preview PDF.
- Andriole, V.T.: Current concepts of urinary tract infections; in Weinstein and Fields (Eds) Seminars in Infectious Diseases, Vol. III, p.89 (Thieme-Stratton, New York 1980).Google Scholar
- Andriole, V.T.: Urinary tract infections and pyelonephritis; in Wyngaarden and Smith (Eds) Cecil Textbook of Medicine, Vol. II, p.619 (W.B. Saunders, Philadelphia 1985).Google Scholar
- Balant, L.; Dayer, P. and Rudhardt, M.: Cefoperazone: Pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats. Clinical Therapy 3: 50 (1980).Google Scholar
- Barr, W. and Graham, R.: Placental transfer of cephaloridine. Placental transmission of cephaloridine. Postgraduate Medicine Journal 43 (Suppl.): 101 (1967).Google Scholar
- Bawdon, R.E.; Cunningham, F.G.; Quick, J.G. and Roark, M.L.: Maternal and fetal pharmacokinetics of moxalactam given intrapartum. American Journal of Obstetrics and Gynecology 141: 546 (1982).Google Scholar
- Buckwold, F.J.; Ludwig, P.; Harding, G.K.M.; Thompson, L.; Slutchuk, M.; Shaw, J. and Ronald, A.R.: Therapy for acute cystitis in adult women: randomized comparison of single-dose sulfisoxazole vs trimethroprim-sulfamethoxazole. Journal of the American Medical Association 247: 1839 (1982).PubMedCrossRefGoogle Scholar
- Cox, C.E.; Sherrill, J.M. and Cocchetto, D.M.: Evaluation of cefuroxime axetil, cefaclor and cephalexin in the treatment of urinary tract infections in adults. Current Therapeutic Research, in press (July, 1987).Google Scholar
- Dabois, M.; Delsneire, D.; Chanteux, L.; Demonty, J.; Lambolte, R.; Kramp, R. and Dresse, A.: A study of the transplacental transfer and the mammary excretion of cefoxitin in humans. Journal of Clinical Pharmacology 21: 477 (1981).Google Scholar
- Elder, H.A.; Sanbmarina, B.A.G.; Smith, S. and Kass, E.H.: The natural history of asymptomatic bacteriuria during pregnancy: The effect of tetracycline on the clinical course and outcome of pregnancy. American Journal of Obstetrics and Gynecology 14: 441 (1971).Google Scholar
- Flakuty, J.F.; Boswell, G.W.; Winkel, C.A. and Elliott, J.P.: Pharmacokinetics of cefoxitin in patients at term gestation: Lavage versus intravenous administration. American Journal of Obstetrics and Gynecology 146: 760 (1983).Google Scholar
- Giamarellou, H.; Petrikkos, G.; Gazis, J.; Tsatsiadis, K.; Antsaklis, A. and Daikos, G.: Penetration of antibiotics with anti-anaerobic activity through the amniotic fluid. Proceedings of the 13th International Congress of Chemotherapy. Section SE 7.6/1-2, p.79/5–8 (1983).Google Scholar
- Kass, E.H.: The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis; in Quinn and Kass (Eds) Biology of Pyelonephritis, p.399 (Little, Brown, Boston 1960).Google Scholar
- Koch, H.K. and McLemore, T.: National Ambulatory Medical Care Survey: 1975 - Summary: United States, January-December 1985. Hyattsville, Maryland: National Center for Health Statistics, Department of Health, Education and Welfare 1: 62 (1978). [Vital and Health Statistics series 13, No. 33. DHEW publications No. (PHS) 78-1784.]Google Scholar
- MacAuley, M. and Charles, D.: Placental transfer of cephalothin. American Journal of Obstetrics and Gynecology 100:940 (1968).Google Scholar
- McFadyen, I.R.; Eykyn, S.J.; Gardner, N.H.N.; Vanier, T.M.; Bennett, A.E.; Mayo, M.E. and Lloyd-Davies, R.W.: Bacteriuria in pregnancy. Journal of Obstetrics and Gynaecology of the British Empire 80: 85 (1973).Google Scholar
- Sandberg, T.; Henning, C.; Paulsen, O. and Iwarson, S.: Cefadroxil once daily for three days versus one week therapy in uncomplicated urinary tract infections. 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Oct. 24–26, 1983. Abstract No. 528 (1983).Google Scholar
- Schwarz, R.H.: Consideration of antibiotic therapy during pregnancy. Obstetrics and Gynecology 58 (Suppl.): 955 (1981).Google Scholar
- Stamey, T.A. (Ed.): Urinary tract infection in women; in Pathogenesis and Treatment of Urinary Tract Infections, p. 164 (Williams and Wilkins, Baltimore 1980).Google Scholar
- Stewart, K.S.: Bacterial infections. Clinics in Obstetrics and Gynecology 8: 315 (1981).Google Scholar
- Williams, J.D.; Reeves, D.S.; Condie, A.P.; Leigh, D.A.; Franklin, I.S.N. and Brumfitt, W.: The treatment of bacteriuria in pregnancy; in O’Grady and Brumfitt (Eds) Urinary Tract Infection, p. 160 (Oxford University Press, London 1968).Google Scholar